Mangoceuticals, Inc.
MGRX
$0.34
$0.012.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 94.40K | 84.20K | 168.10K | 109.30K | 105.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 94.40K | 84.20K | 168.10K | 109.30K | 105.20K |
| Cost of Revenue | 46.90K | 33.30K | 78.20K | 47.20K | 25.10K |
| Gross Profit | 47.50K | 50.90K | 89.90K | 62.10K | 80.10K |
| SG&A Expenses | 412.30K | 7.56M | 5.25M | 3.50M | 1.74M |
| Depreciation & Amortization | 1.12M | -- | -- | -- | 721.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.58M | 7.59M | 5.33M | 3.54M | 2.49M |
| Operating Income | -1.49M | -7.51M | -5.16M | -3.43M | -2.38M |
| Income Before Tax | -2.77M | -7.62M | -5.42M | -4.84M | -1.95M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.77M | -7.62M | -5.42M | -4.84M | -1.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -200.00 | 600.00 | 0.00 | 100.00 | 200.00 |
| Net Income | -2.77M | -7.62M | -5.42M | -4.84M | -1.95M |
| EBIT | -1.49M | -7.51M | -5.16M | -3.43M | -2.38M |
| EBITDA | -1.04M | -7.48M | -4.33M | -3.02M | -1.66M |
| EPS Basic | -0.22 | -0.69 | -0.54 | -1.05 | -0.74 |
| Normalized Basic EPS | -0.07 | -0.41 | -0.33 | -0.66 | -0.46 |
| EPS Diluted | -0.22 | -0.69 | -0.54 | -1.05 | -0.74 |
| Normalized Diluted EPS | -0.07 | -0.41 | -0.33 | -0.66 | -0.46 |
| Average Basic Shares Outstanding | 14.19M | 11.52M | 9.98M | 4.59M | 2.62M |
| Average Diluted Shares Outstanding | 14.19M | 11.52M | 9.98M | 4.59M | 2.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |